Cognitive Decline in Older Adults

2

Review clinical trials related to Cognitive Decline in Older Adults. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes

Type 2 diabetes and low levels of physical activity are associated with an increased risk of cognitive decline in older adults. Improving blood sugar control and engaging in regular exercise may help support brain health and physical function in this population. The MOTIVATE study is a randomized clinical trial designed to examine the effects of supervised exercise and diabetes treatment with semaglutide, alone or in combination, on cognitive function, physical health, and brain-related outcomes in older adults with Type 2 diabetes. Participants will be assigned to one of four study groups involving exercise training, control exercise, semaglutide treatment, or standard diabetes care. Participants will complete supervised exercise sessions three times per week for 32 weeks, with some participants also receiving weekly semaglutide injections for 16 weeks. Assessments will include cognitive testing, physical and functional measures, blood-based metabolic markers, and brain imaging. This study aims to improve understanding of how exercise and diabetes treatments may support brain health in older adults with Type 2 diabetes.

Participants needed: 164
Trial details
Phase: Phase 4Age: 65+Biological sex: AllType: InterventionalSponsor: Western University, CanadaUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Informed consent obtained before any trial-related activities. Trial-related act... [+12]

Have a medical condition for which semaglutide or exercise is contraindicated [+1]

Status: Not yet recruiting

Tech-based Respite Care for Caregivers and Homebound Older Adults

The goal of this study is to examine the effectiveness of VR-based respite in improving cognitive function, mental health, and quality of life in caregivers and homebound older adults compared to a control group using videos and a usual care group. Participants are randomly assigned to one of three groups: VR intervention, video control, or usual care. The VR group receives immersive VR sessions using the SilVR Adventures platform. The video group receives non-immersive video sessions with similar content. The usual care group receives no additional intervention. Assessments are conducted at baseline, immediate post-intervention, and 3 months post-intervention to measure changes in depression, anxiety, loneliness, quality of life, and other outcomes. The intervention dosage will be 4 weeks (1 sessions/week; 30 min/session). Secondarily, the study explores differences in effectiveness between caregivers and homebound older adults, and potential moderators or mediators such as baseline health status, technological literacy, and social support.

Participants needed: 180
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hong Kong UniversityUpdated: Sep 12, 2025Locations: 1
Eligibility criteria

Aged 18 or above [+5]

History of severe psychiatric disorders (e.g., schizophrenia, bipolar) [+11]